611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Medical Disorders
Basic InformationLookupsLatest News
When Is It Time for a Knee Replacement?AHA News: Death Rates From Tears In This Major Heart Artery Are Rising, Especially Among Women, Black AdultsOmicron COVID Causing Severe Croup in Young Children'Zapping' Air Passages May Bring Relief for Severe AsthmaModerna Asks FDA to Approve Second Booster for All AdultsNew Tick-Borne Virus Is Spreading Across U.S.Memory Issues Plague Long COVID PatientsCOVID Vaccine Won't Cause Rare Neuro Events, But COVID Infection CouldTriglycerides a Stroke Danger, Even With Statin TreatmentIt Can Take Weeks for Some Patients With Severe COVID to Recover ConsciousnessOmicron Wave Had 5 Times as Many Small Kids Hospitalized Compared to DeltaBreathing Dirty Air Could Raise Your Odds for Rheumatoid ArthritisPalliative Care Crucial After Severe Stroke, But Many Patients Miss OutMammograms Can Also Highlight Heart Risks: StudyPfizer Asks FDA to Approve Second Booster for SeniorsEven a Little Light in Your Bedroom Could Harm HealthMental Issues Can Linger More Than a Year After Severe COVIDRise in U.K. COVID Cases Closely Watched by U.S. Health OfficialsLong COVID May Bring Long-Term Lung DamageNew Malaria Treatment Gets First Approval for Use in ChildrenWarming World Means More Cases of Dangerous Low-Salt ConditionAbout 1 in 6 U.S. Couples Disagrees on COVID VaccinationCOVID Meds Appear to Work Against BA.2 Omicron Variant‘Deltacron’ Variant Rare and Not a Major ConcernCould Depression Make Dry Eye Worse?When Will Americans With Diabetes Get Relief From High Insulin Prices?COVID's Global Death Toll May Be 3 Times Official NumbersDrug Could Be Non-Antibiotic Alternative to Treat UTIsFlu Vaccine No Match for Circulating Variants This SeasonLymphedema in Legs Strikes 1 in 3 Female Cancer SurvivorsScience Brings Shortcut to Spotting 50 Rare Genetic DiseasesU.S. Airplane, Train and Transit Mask Mandates Extended to April 18Man Who Received First Pig Heart Transplant Has DiedPfizer Begins Trial of COVID Drug Paxlovid in Kids 6 to 17Could a Stool Test Help Spot Pancreatic Cancer?Upcoming Surgery Worry You? Poll Says You're Not AloneHalf of Americans Live With Legacy of Childhood Lead PoisoningIn Reversal, WHO Now Supports COVID BoostersLooking to Neanderthals to Explain Today's Lower Back PainWhat's More Accurate, Blood Pressure Readings at Home or Doctor's Office?Begin Now to Protect Your Heart as Clocks 'Spring Forward'Brain Changes May Fuel 'Long COVID' Anxiety, ConfusionAHA News: Break Up Binge-Watching by Taking a StandHow COVID-19 Can Change the BrainHeart Defects Could Raise Odds for Severe COVID-196 Healthy Steps to Preventing Colon CancerAHA News: These Three Risk Factors May Have the Biggest Impact on Dementia CasesU.S. Surgeon General Investigates COVID-19 MisinformationLong or Irregular Periods May Put a Woman's Liver at RiskCould Your Blood Type Make COVID Worse?
Questions and AnswersLinksBook Reviews
Related Topics

Men's Health
Women's Health

Moderna Asks FDA to Approve Second Booster for All Adults

HealthDay News
Updated: Mar 18th 2022

new article illustration

FRIDAY, March 18, 2022 (HealthDay News) -- Moderna said late Thursday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster of its COVID vaccine for all adults.

In a statement, the company noted its request is based partly on recent data from the United States and Israel showing how well its vaccine protects against the Omicron variant.

Moderna has asked for much broader authorization for a second booster than Pfizer did when it requested FDA emergency use authorization of a second booster of its vaccine for adults 65 and older earlier this week. In doing so, Moderna explained that its request covered all adults to give federal health officials the freedom to determine who should get a second booster, including for those at higher risk of severe disease because of age or underlying medical conditions.

U.S. health officials have expressed concerns about the waning power of Moderna and Pfizer booster shots that were authorized last fall. There are signs the FDA could respond quickly to Pfizer's request for a second booster, but it's unclear how the agency will view Moderna's request, The New York Times reported.

In the meantime, experts are engaged in an intense debate over whether a second booster is needed at the moment.

“I’m a strong proponent of giving a second booster now," Dr. Peter Hotez, a vaccine expert at the Baylor College of Medicine in Houston, told the Times.

The first booster shot “made a huge difference” in improving protection against hospitalization and even infection from the Omicron variant, Hotez noted.

“It’s also clear that protection is waning now pretty quickly, a few months after your third dose,” he said. “So, it’s short-lived. The hope is that a second booster would restore it.”

But there are still a number of questions that need to be answered before approving second boosters, according to Dr. Jesse Goodman, a former chief scientist for the FDA.

“While protection is waning against mild infections, without more information we do not yet know to what extent, if any, protection is waning against severe disease,” he told the Times.

It's also not clear “to what degree and for how long another booster might help," Goodman added.

A U.S. Centers for Disease Control and Prevention study released last month said the protection of the Pfizer and Moderna vaccines against hospitalization fell from 91% two months after a booster shot to 78% after four months, but that research did not break down hospitalizations by factors such as age or the presence of underlying conditions, the Times reported.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on COVID boosters.

SOURCE: The New York Times